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Background: The aim of this study was to evaluate oxidative stress in various clinical forms 
of hepatitis B infection and to investigate its role in the development of the chronic form of 
the disease.
Methods: Ninety-three patients with inactive hepatitis B surface antigen (HbsAg) carrier 
state (IHBCS), 65 patients with chronic hepatitis B infection (CHB), and 42 healthy adults 
were included in the study. The following values were measured and compared in patient 
groups: total antioxidant status (TAS), total oxidative stress (TOS), oxidative stress index 
(OSI), sulfhydryl (SH), lipid peroxidation (LOOH), catalase (CAT), and ceruloplasmin. In 
patients with chronic hepatitis B, these values were compared with HBV DNA and fibrosis 
levels.
Results: ALT, TOS, LOOH, and OSI levels were higher in the CHB group compared to the 
other groups (P<0.001). Catalase levels increased in the CHB and IHBCS groups compared 
to the control group (P<0.001). Total aminooxidant and ceruloplasmin levels were found 
to be lowest in the CHB group and highest in the control group (P<0.001). Sulfhyrdyl was 
higher in the control group compared to the other groups (P<0.001). In the CHB group, 
there was no correlation between the HBV DNA and OSI (P>0.05).
Conclusions: These finding suggested that oxidative stress is associated with hepatitis B 
activity.
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INTRODUCTION
The hepatitis B virus (HBV), which is a chronic viral hepatitis 
factor, is a significant pathogen that causes fibrosis, cirrhosis, 
hepatocellular cancer as a result of the damage it causes to liver 
cells. Chronic hepatitis B (CHB) infection is a health issue that 
affects more than 400 million people globally. Although there is 
an effective vaccine and advances have been made in diagnos-
tic and treatment methods, almost 1,000,000 people die every 
year due to HBV infection-related complications [1]. Hepatitis B 
infection exhibits a varied clinical course, which can range from 
asymptomatic infection to fulminant liver disease [2].
  Cells continuously form free radicals and reactive oxygen spe-
cies as part of metabolic processes. These free radicals and re-
active oxygen species are neutralized by a complex antioxidant 
system. Oxidative stress is the imbalance that occurs between 
the reactive oxygen species or free radicals and the antioxidant 
system, and this imbalance may cause irreversible damage in 
important cellular compartments.
  In chronic viral hepatitis, the role of oxidative stress in cell de-
struction and DNA and RNA damage has been established 
through experimental studies [3, 4]. In the present study, oxida-
tive stress was measured in various clinical forms of the chronic 
hepatitis B and its role was investigated in the development of 
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chronic hepatitis. 
METHODS
1. Patient selection and sample preparation 
Patients infected with hepatitis B virus, who presented to Tokat 
State Hospital (in Tokat, Turkey) between June 2010 and May 
2011, and healthy adults participated in the study. A total of 200 
individuals participated in the study, comprising 65 chronic ac-
tive hepatitis B patients in the 15-66 age range (32.5%), 93 pa-
tients with inactive hepatitis B infection (46.5%) and 42 healthy 
adults. All subjects who participated in the study gave informed 
consent and the study was approved by the Ethics Committee 
of the Harran University, Faculty of Medicine. 
1) Diagnosis criteria
The disease was diagnosed according to the following criteria [5].
Chronic hepatitis B infection (CHB): 
(1) HBsAg-positive for more than 6 months,
(2)     ALT value greater than 1.5 times the normal value (nor-
mally, ALT value is less than 40 IU/mL), 
(3)     HBV DNA value  ≥100,000 copies/mL (20,000 IU/mL) in 
those who were postitive for the hepatitis Be antigen 
(HBeAg-positive), 
(4)     Whereas it was ≥10,000 copies/mL (2,000 IU/mL) in those 
who were HBeAg-negative, and
(5) Fibrosis ≥2 in the histopathological evaluation of the liver 
Inactive HbsAg Carrier State (IHBCS):
(1) HBsAg-positive,
(2) Normal ALT values,
(3) HBeAg-negative, and
(4) HBV DNA ≤10,000 copies/mL (2,000 IU/mL)
  The control group was formed from HBsAg-negative healthy 
adults whose anti-HBc total value was negative.
Exclusion criteria: Patients with liver cirrhosis, diabetes mellitus, 
hypertension, coronary artery disease, acute infection, chronic 
obstructive pulmonary disease, corticosteroid usage, malignancy, 
morbid obesity, pregnancy, liver and kidney failure, and smok-
ers were not included in the study.
Liver biopsy was performed on all patients with CHB prior to 
treatment. In order to rate the liver damage, histological activity 
(necroinflammatory lesion) and fibrosis (according to KNODELL 
fibrosis scoring system) [6] assessment was performed.
  In addition to the patient’s age, gender, HBsAg, HBeAg, anti-
HBe, ALT, and AST values, HBV DNA levels and liver biopsy, fi-
brosis levels were also recorded in chronic hepatitis B patients. 
2) Collection and storage of samples 
Blood samples were collected in the form of venous blood follow-
ing 12 hr of fasting. Physical examination was performed on the 
patients to exclude other diseases. Ten milliliter blood samples 
were collected into biochemistry tubes containing heparin. The 
plasma, which was obtained after centrifuging blood samples at 
3,500 rpm for 10 min, was stored at -80ºC until the study date.
2. Measurement of oxidative status
Total oxidative status (TOS), total antioxidant status (TAS), and 
oxidative stress index (OSI) were measured using the method 
developed by Erel [7]. In this method, long-lasting, durable, rad-
ical monocation of 2,2´-azinobis-(3-ethylbenzothiazoline-6-sul-
fonic acid) (ABTS) is formed. The color of this radical, which is 
characteristically blue-green, is reduced by the antioxidants and 
disappears. The lightening and/or discoloration of the color of 
the antioxidants in the samples is considered to be their total 
antioxidant capacity. Trolox, which is a water-soluble analog of 
vitamin E, was used as the standard, and the results were ex-
pressed in terms of µmol trolox equiv./L [7]. 
  The serum catalase (CAT) activity was determined using Goth’s 
colorimetric method [8], in which serum is incubated with H2O2, 
and the enzyme reactions are stopped by the addition of am-
monium molybdate. Serum CAT activity was expressed as kU/L.
  Free sulfhydryl groups of serum samples were assayed accord-
ing to the method of Ellman [9], as modified by Hu et al. [10]. 
Briefly, 1 mL of buffer containing 0.1 M Tris, 10 mM EDTA, pH 
8.2, and 50 µL serum was added to cuvettes, followed by 50 µL 
10 mM 5,5′-dithio-bis (2-nitrobenzoic acid) (DTNB) in methanol. 
Blanks without DNTB in the methanol were run for each sample 
as a test. Following incubation for 15 min at room temperature, 
sample absorbance was measured at 412 nm using a spectro-
photometer (CE1011; Cecil Instruments Ltd., Milton Technical 
Centre, Cambridge, England). The value of reagent blanks were 
subtracted from those of samples for calibration. The concen-
tration of sulfhydryl groups was calculated using reduced gluta-
thione as the free sulfhydryl group standard and the result was 
expressed as mmol/L.
  Plasma lipid peroxidation (LOOH) was evaluated by the fluori-
metric method based on the reaction between malondialdehyde 
(MDA) and thiobarbutiric acid (TBA) [11]. Briefly, 50 µL of plasma 
was added to 1 mL of 10 mmol/L diethythiobarbutiric acid (DETBA) Duygu F, et al.
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reagent in phosphate buffer (0.1 mol/L, pH 3). The mixture was 
mixed for 5 sec and incubated for 60 min at 95ºC. Samples were 
placed on ice for 5 min and then 5 mL of butanol was added. 
The mixture was shaken for 1 min to extract the DETBA-MDA 
adduct, and then centrifuged at 1,500×g for 10 min at 4ºC. Flu-
orescence of the butanol extract was measured at an excitation 
wavelength of 539 nm and an emission wavelength of 553 nm. 
1,1,3,3,tetraethoxypropane (Sigma Chemical Company, St. Louis, 
MO, USA) was used as a standard solution and the values were 
presented as mol/L.
  Ceruloplasmin levels were assessed by measuring its oxida-
tive activity using p-phenylenediamine as the substrate, accord-
ing to the method of Sunderman and Nomoto [12].
3. Statistical analysis
Pearson’s chi-square test was used to compare the categorical 
variables between groups. Categorical variables were presented 
as counts and percentages. The Shapiro-Wilk test was used to 
evaluate whether the distribution of variables was normal. 
  The t-test for two independent samples, or the Kruskal-Wallis 
test, was used to compare continuous variables between two 
groups. Continuous variables were presented as mean (SD) or 
as median (interquartile range [IQR]). A P value of less than 
0.05 was considered to be statistically significant. SPSS software 
15.0 for Windows (Chicago, IL, USA) was used for all statistical 
analyses.
RESULTS 
The chronic hepatitis B, inactive hepatitis B, and control groups 
were similar in terms of mean age of the subjects (P>0.05). There 
was no significant difference in gender characteristics between 
the CHB group and the other groups (IHBCS, Control) (P=0.103 
and P=0.656, respectively). The gender distribution of the IH-
BCS and control groups were also similar (P=0.35). 
  Of the chronic hepatitis B patients, 32 (49.2%) were HBeAg-
positive. The age and gender characteristics and ALT values of 
the patients are shown in Table 1. The ALT level was higher in 
the CHB group compared to the other two groups (P<0.001). A 
positive correlation was found between ALT and HBV DNA (r= 
0.308; P=0.012). There was no correlation between ALT and ox-
idative stress (P>0.05). The oxidative and antioxidative parame-
ters in each group are shown in Table 2. The values of OSI, TAS, 
and ceruloplasmin of the patient and control groups are shown 
in Figs. 1-3, respectively. In the CHB group, no correlation was 
found between the fibrosis levels of the patients and oxidative 
stress (P>0.05). In patients in the CHB group, HBV DNA was 
not correlated with OSI (P>0.05). A strong negative correlation 
was observed between OSI and TAS (r=-0.404; P<0.001) and 
between OSI and SH (r=-0.333; P=0.015). A strong positive 
correlation was observed between OSI and LOOH (r=0.731; 
P<0.001) and TOS (r=0.731; P<0.001).
Table 1. The clinical and demographic data of the study groups
Item Chronic hepatitis 
B (N=65)
Inactive HBsAg 
carrier state 
(N=93)
Control
(N=42) P
Age (yr), mean (SD) 31.82±12.59 33.7±12.81 33.29±12.8 >0.05
Male, n (%) 45 (48.4%) 40 (61.5%) 24 (57.1%) >0.05
Alanine 
Aminotransferase 
  (IU/mL), median  
  (IQR)
81 (53.5-133) 21 (16-31)
20.5 (11.75-
29.25)
<0.001*
*There was a statistically significant difference between the CHB group and 
the other groups.
Table 2. Oxidative and antioxidative parameters in each group
Chronic hepatitis B (N=65) Inactive HbsAg carrier state (N=93) Control (N=42) P
TAS (µmol Trolox equivalents/L), mean (SD) 0.74±0.103 0.79±0.107 0.91±0.13 <0.001*
CAT (kU/L), median (IQR) 17.33 (14.77-18.50) 17.95 (16.85-8.82) 8.5 (7.7-9.2) <0.001
†
SH, mean (SD) 0.23±0.027 0.24±0.026   0.28±0.027 <0.001
‡
Looh (mol/L), median (IQR) 6.82 (5.03-10.31) 5.19 (4.89-5.96) 5.94 (4.72-6.92) <0.001
§
TOS (µmol Trolox equivalents/L), median (IQR) 12.87 (8.62-16.93) 8.4 (7.38-10.77) 9.47 (7.61-10.43) <0.001
§
Serulop, median (IQR) 510.62 (486.25-544.37) 540 (504.21-588.12) 663.28 (624.60-746.87) <0.001*
OSI (µmol Trolox equivalents/L), median (IQR) 1.75 (1.15-2.13) 1.09 (0.93-1.4) 1.01 (0.88-1.16) <0.001
§
*There was a statistically significant difference between all groups; 
†There was a statistically significant difference between the control group and the other 
groups (P<0.001) and no statistically significant difference between the chronic hepatitis B group and the inactive HBsAg carrier state group (P<0.005); 
‡There was a statistically significant difference between the control group and the other groups but no statistically significant difference between the chronic 
hepatitis B group and the inactive HBsAg carrier state group; 
§There was a statistically significant difference between the chronic hepatitis B group and the 
other groups but no statistically significant difference between the inactive HBsAg carrier state group and the control group.Duygu F, et al.
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DISCUSSION
In this study, we showed that in hepatitis B infection, oxidative 
stress indices such as TOS, LOOH, OSI, and CAT are increased, 
and TAS, sulfhydryl, and ceruloplasmin levels, which are indica-
tive of antioxidant status, are decreased. 
  The HBV is one of the important factors of acute/chronic 
hepatitis, cirrhosis and hepatocellular carcinoma. More than 
400 million people are known to be chronically infected with 
HBV [13]. Five percent of the world population are HBV carriers 
and CHB infection is cited by WHO to be the ninth most com-
mon cause of death [1].
  Hepatitis B infection exhibits a varied clinical course, which 
can range from asymptomatic infection to fulminant liver disease 
[2]. The disease is diagnosed through clinical, microbiological 
(ELISA, PCR), biochemical (ALT, AST), and pathological assess-
ment [14]. In the present study, oxidative stress parameters in 
two different forms of the disease (CHB and IHBCS) were com-
pared to those in healthy adults.
  The liver fibrosis levels of the patients were determined through 
the histological assessment of the liver biopsy material. The di-
agnosis of the patients included in the study was made based 
on these four methods, i.e. clinical, microbiological, biochemi-
cal, and pathological method. HBV DNA analysis and histologi-
cal assessments of liver biopsy samples were performed for all 
CHB patients.
  Free radicals are defined as short-lived, unstable, and highly 
active molecules with one or more unpaired electrons, and with 
low molecular weight [15, 16]. The substances that can prevent 
or delay the effects of molecules that may cause oxidation of es-
sential substances in an organism are called antioxidants [17]. 
Oxidative stress is defined simply as the imbalance between the 
body’s antioxidant defense and the production of the free radi-
cals, which can cause peroxidation of the lipid layer of the cells 
[18, 19]. The main intracellular antioxidants in humans are the 
superoxide dismutase (SOD), catalase (CAT), and glutathione 
peroxidase (GPx) enzymes. In contrast to the intracellular envi-
ronment, vitamins E and C, transferrin, haptoglobin, ceruloplas-
min, albumin, bilirubin, β-carotene, and alpha-l-antitrypsin are 
responsible for antioxidant defense in the extracellular environ-
ment [20].
  The free fatty acid (FFA) oxidation products (lipid peroxide, 
superoxide, and hydrogen peroxide radicals) can generate oxi-
Fig. 1. Oxidative stress index values of patient groups and control 
group.
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Fig. 2. Totally antioxidant status values of patient groups and con-
trol group.
Abbreviation: TAX, totally antioxidant status.
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dative stress and result in subsequent lipid peroxidation. Lipid 
hydroperoxide (LOOH), which is a non-radical free oxygen parti-
cle, is one of the indicators for oxidative stress [21]. In recent 
years, the role of the imbalance between oxidative stress and the 
antioxidant status in cell destruction has become better under-
stood [3, 7, 22].
  Free oxygen radicals are effective in the pathogenesis of many 
diseases such as carbon tetrachloride-associated liver damage, 
glomerulonephritis, arteriosclerosis, diabetes mellitus, vitamin 
C-E deficiency, malignancy, emphysema, hyperoxia, bronchopul-
monary dysplasia, pancreatitis, and rheumatoid arthritis [22-24].
  In infectious diseases, inflammatory cells have been shown to 
become activated and secrete reactive oxygen and nitrogen spe-
cies. Studies on oxidative stress have been conducted in many 
infectious diseases and oxidative stress has been demonstrated 
to increase in leishmania, measles, Neisseria gonorrhoeae in-
fections, sepsis, urinary system infections, and Paracoccidioides 
brasiliensis infections [25-30]. 
  There have been various studies indicating that oxidative stress 
is increased in hepatitis B and hepatitis C infections and in liver 
disease [31-35]. Increased oxidative stress in HBV infection was 
demonstrated to have an effect on DNA damage and hepato-
carcinogenesis [16]. It is known that of the 530,000 hepatocellu-
lar carcinoma cases seen each year, 316,000 are associated with 
HBV [2]. Therefore, we believe oxidative stress, which is known 
to play a significant role in hepatocarcinogenesis, is important in 
CHB patients. 
  Various indicators of oxidative stress have been studied in var-
ious clinical forms of hepatitis B and have been demonstrated to 
increase as the disease becomes chronic [4, 35].
  Measurement of the overall antioxidant status may yield more 
valuable information than the measurement of individual antioxi-
dants. In our study, we chose to use the total antioxidant capacity 
measurement method developed in recent years by Erel, which 
measures total SH, vitamin C, uric acid, vitamin E, bilirubin, and 
many other antioxidants precisely, and the total oxidant capacity 
measurement method, which measures the oxidative stress 
caused by free radicals in the plasma such as hydroxyl (OH), 
hydrogen peroxide (H2O2), singlet oxygen (O2
↑ ↓), lipid hydroper-
oxide (LOOH), and superoxide (O2
.-), which can all be measured 
with ease due to the fact that these measurements can be per-
formed by fully automated colorimetric methods [7, 19]. In the 
present study, OSI, TOS, and TAS measurements were performed 
using this method. Additionally, ceruloplasmin, LOOH, and SH, 
which are also oxidative stress indicators, and SH and CAT en-
zymes, which are antioxidant status indicators, were assessed 
and compared in IHBCS, CHB and control groups. 
  The values of OSI, TOS, and LOOH, which are oxidative stress 
indicators, were higher in the CHB group compared to the other 
groups (P<0.001). The values of the antioxidant status indicator 
TAS, the intracellular antioxidant CAT, and the extracellular anti-
oxidant ceruloplasmin were different in all three groups, and 
thus they decreased with increasing severity of the disease (P< 
0.001). This suggested that oxidative stress may play a role in 
the pathogenesis of CHB and in exacerbation of the disease. 
This study is the first study to compare oxidative stress with 
HBV DNA. Our data indicate no correlation between OSI and 
HBV DNA. 
  In chronic hepatitis B, the gold standard in assessing fibrosis 
is the histopathological examination of the liver biopsy material. 
The histological activity index (HAI) and fibrosis level in the liver 
indicates the progression of the disease toward cirrhosis. This 
study investigated the relationship of oxidative stress with fibro-
sis. We did not find a correlation between HAI and fibrosis and 
the indicators of oxidative stress. We believe this may be in part 
due to the homogeneity of the patients in whom the biopsies were 
performed, exclusion of patients with liver cirrhosis from the 
study, and the presence of moderate chronic active hepatitis in 
all patients.
  In conclusion, oxidative stress increases and antioxidant val-
ues decreases as the disease becomes chronic in patients with 
hepatitis B infection. This study suggests that oxidative stress 
may be associated with hepatitis B activity. 
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